| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |